Glaxosmithkline Share News (GSK)

Analysts see possible windfall from GSK spin-offs

LONDON, April 24 (Reuters) - GlaxoSmithKline shareholders could be in line for a possible windfall after the drugmaker put two drinks brands up for s
[24 Apr '13]

UPDATE 2-GSK puts Lucozade and Ribena drink brands up for sale

* Analysts see drinks selling for more than 1 billion pounds* GSK also to create division for older pharma products* Q1 sales down 3 pct at 6.47 bln s
[24 Apr '13]

GSK opts to sell off Lucozade and Ribena drink brands

LONDON, April 24 (Reuters) - GlaxoSmithKline has decided to sell its popular soft drink brands Lucozade and Ribena in a disposal that could bring in m
[24 Apr '13]

Novartis says new drug brings relief to lung patients

ZURICH, April 23 (Reuters) - Swiss drugmaker Novartis said on Tuesday results from a 64-week study showed daily treatment with one of its investigati
[23 Apr '13]

GSK to partner with venture capital firm for drug discovery

April 22 (Reuters) - GlaxoSmithKline said on Monday it will partner with venture capitalists Avalon Ventures in a deal worth up to $495 million to fun
[22 Apr '13]

UK blocks Shell paying Iran oil debt in food, medicine

By Richard MablyLONDON, April 22 (Reuters) - Britain has blocked efforts by oil major Royal Dutch Shell to settle a $2.3 billion debt it owes Iran by
[22 Apr '13]

Astellas, GSK vie to make 'high altitude' anaemia pill

* Drugs mimic body's response to being at high altitude* Experimental tablets an alternative to injections of EPO* Astellas and partner FibroGen in le
[19 Apr '13]

RPT-Fitch Publishes EMEA 2012 Pharmaceuticals Companies Dashboard

April 19 (Reuters) - (The following statement was released by the rating agency)Fitch Ratings has published the EMEA 2012 Pharmaceuticals Companies da
[19 Apr '13]